“To be the change in an ever evolving world through enrichment of living”
Background to Mission Statement:
Humanity is currently undergoing a phase of massive growth. Along with increases in global population levels, those currently alive today may well see their life expectancies increase by a factor greater than anything seen before in human history.
The concept of ‘living’ will be redefined in this era.
Humanity will transition from an age of ‘how long we can live’ to one of ‘how we should live’.
By making use of the regenerative powers of iPSC therapies, we will heal and bring hope to those worldwide who are suffering.
We will create a global infrastructure to develop, manufacture and promote our therapies from within the Healios family of businesses.
We will build a biotechnology company founded on solid principles in which every individual can trust.
Are we thinking of and supporting our patients the best we can, using our time the most efficiently, giving our patients hope, and providing our patients with the latest and most effective treatments?
2. Path Finder
Are we blazing new trails?
3. Jump in 60
Are we able to go in to battle only 60% ready ?
4. Team Work
Are we able to lean on our co-workers in time of need?
5. Look straight, Think straight, Talk straight
Are we able to perceive and talk objectively about things without bias?
6. There is no bad weather, only bad clothing
Are we ready for when it rains?
7. Shining 100
Are we able to grasp the point immediately and, while following through 100%, pay close attention to detail to ensure nothing is neglected?
Are we able to visualize and realize an endless cycle of growth in adherence to our other core values?.
The name Healios is a combination of the name of
Helios (God of the Sun in Greek mythology) and the word “heal,”
in the hopes that we can provide a ray of light (hope) by providing treatments
for intractable diseases to heal the afflicted.
This concept guides our efforts to carry out technical development
for regenerative medicine for diseases that affect the tissues in the human body
in the form of iPSC regenerative drugs and to be a worldwide pioneer
in gaining approval for these drugs in order to provide many patients
with treatments as soon as possible.